AAIH Announces Inaugural Board of Directors and Officers After Formal Launch
WASHINGTON, DC, January 22, 2019 – The Alliance for Artificial Intelligence in Healthcare (AAIH) announced today that it has formally launched after the inaugural meeting of its 22-person Board of Directors.
During the inaugural meeting held on January 9 in San Francisco at Amazon Web Services, the Board appointed the following Executive Officers: John Baldoni, former Senior Vice President at GSK was elected Chair; Brandon Allgood, Co-Founder and Chief Technology Officer of Numerate, was elected Vice Chair; Angeli Moeller, co-Lead of AI and Head of IT Business Partnering Research at Bayer was elected Treasurer; and Naheed Kurji, President & CEO of Cyclica Inc. was elected Secretary.
“In selecting industry experts from established and emerging companies to lead AAIH, the Board has demonstrated its commitment to the integration of AI across the full spectrum of healthcare with the goal of improving patients’ lives by creating more efficient, sustainable and accessible biomedical research and healthcare systems,” said Annastasiah Mudiwa Mhaka of Adjuvant Partners, who will be serving as the President of the organization.
In addition to naming executive officers, the AAIH Board identified six standing committees that will oversee AAIH’s work in promoting advancement of AI. They are Education and Accreditation, Federal Engagement and Regulatory Affairs, Investment and Commercialization, Communications, Technology and Standards Development, and Industry Performance and Data Analytics.
Over the next several months the AAIH Board and its committees will begin developing strategy and initiatives aimed at educating the public about the benefits and risks of AI, promoting investment in AI-related research and development, and working with government officials in the U.S., European Union and other jurisdictions to develop regulatory and technology standards.
“In recent years AI companies have begun implementing increasingly sophisticated machine learning techniques to significantly mitigate and, in some cases, eliminate inefficiencies in the current healthcare system,” Naheed Kurji added. “These innovations have accelerated growth of AI in the healthcare industry, and engendered enthusiasm and hope in consumers and patients alike. AAIH will work to collaboratively help bring these new health care advances to patients world-wide.”
“In recent years AI companies have begun implementing increasingly sophisticated machine learning techniques to significantly mitigate and, in some cases, eliminate inefficiencies in the current healthcare system. These innovations have accelerated growth of AI in the healthcare industry, and engendered enthusiasm and hope in consumers and patients alike. AAIH will work to collaboratively help bring these new health care advances to patients world-wide.”
AAIH’s founding companies and organizations include Amazon Web Services (AWS), Bayer, Beyond Limits, BlackThorn Therapeutics, The Buck Institute for Research on Aging, Cyclica, Envisagenics, GE Healthcare, Genialis, GSK, Insilico Medicine, Johnson & Johnson, minds.ai, Netrias, NuMedii, Numerate, Nuritas, Owkin, Progenics Pharmaceuticals, Recursion, SimplicityBio, and University of Pittsburgh.
About the Alliance for Artificial Intelligence in Healthcare (AAIH)
The AAIH is a multi-stakeholder 501(c) (4) non-profit advocacy and education organization dedicated to promoting the further development and implementation of AI in healthcare. The membership-based alliance is a coalition of technology developers, pharmaceutical and device companies, research organizations and other associations engaged in advancing AI in the healthcare industry. To learn more about the AAIH, including partnerships and opportunities to support its programs, visit http://www.theaaih.org.
Opus Biotech Communications
Dan Eramian, email@example.com, 425-306-8716
Charles Craig, firstname.lastname@example.org, 404-245-0591.